| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/24/2003 | CN1444598A Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of immune response to amyloid beta and amyloid deposits |
| 09/23/2003 | US6623940 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 09/23/2003 | CA2139632C Assay for chagas' disease and reagents for its use |
| 09/23/2003 | CA2082424C Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 09/18/2003 | WO2003076621A2 Vpr modulators and uses thereof |
| 09/18/2003 | WO2003076571A2 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 09/18/2003 | WO2003076469A2 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
| 09/18/2003 | WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides |
| 09/18/2003 | WO2003075845A2 Immunogenicity of glucan binding protein |
| 09/18/2003 | WO2002094868A3 Staphylococcus aureus proteins and nucleic acids |
| 09/18/2003 | WO2002077174A3 Human cytokine receptor |
| 09/18/2003 | WO2002066646A3 Neurotransmission-associated proteins |
| 09/18/2003 | WO2002059308A3 Method of diagnosing and treating cartilage disorders |
| 09/18/2003 | WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease |
| 09/18/2003 | US20030176673 Fermentation of fusion protein; genetic engineering |
| 09/18/2003 | US20030176644 Compositions and methods for molecular biology |
| 09/18/2003 | US20030176352 Peptides and related compounds having thrombopoietic activity |
| 09/18/2003 | US20030176338 Novel serine-threonine kinase |
| 09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
| 09/18/2003 | US20030175975 Using plasmid Dna; cyclic peptide |
| 09/18/2003 | US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/18/2003 | US20030175895 Chemokine |
| 09/18/2003 | US20030175884 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 09/18/2003 | US20030175859 Fluorescent proteins |
| 09/18/2003 | US20030175807 Chimeric GFP-aequorin as bioluminescent Ca+at the single cell level |
| 09/18/2003 | US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 09/18/2003 | US20030175296 Chimaeric hepadnavirus core antigen proteins |
| 09/18/2003 | US20030175289 TIE ligands |
| 09/18/2003 | US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 09/18/2003 | US20030175252 Therapeutic compounds for ovarian cancer |
| 09/18/2003 | CA2480962A1 Immunogenicity of glucan binding protein |
| 09/18/2003 | CA2478593A1 Cancer-linked gene as target for chemotherapy |
| 09/18/2003 | CA2478369A1 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 09/17/2003 | EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins |
| 09/17/2003 | EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 09/17/2003 | EP1343889A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 09/17/2003 | EP1343888A2 Regulation of human chemokine-like receptor |
| 09/17/2003 | EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/17/2003 | EP1343884A2 Jfy1 protein induces rapid apoptosis |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | CN1443243A 修饰的病毒 Modified viruses |
| 09/17/2003 | CN1443239A Compositions and methods for therapy and diagnosis of breast cancer |
| 09/17/2003 | CN1443196A Protein complex serving as vehicle for orally administerable medicaments |
| 09/17/2003 | CN1442430A AsLc-IFN fusion protein and its preparation |
| 09/16/2003 | US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs |
| 09/16/2003 | US6620784 Uses of VEGF-E |
| 09/16/2003 | US6620413 Obesity protein derivative covalently bonded to a nonproteinaceous polymer, wherein said derivative is capable of reducing body weight and/or food intake in an individual |
| 09/16/2003 | CA2140252C A snow grooming device |
| 09/12/2003 | WO2003065973A8 Multivalent streptococcal vaccine compositions and methods for use |
| 09/12/2003 | WO2003035884A3 Transient immortalization |
| 09/12/2003 | WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 09/12/2003 | WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/12/2003 | WO2002018572A3 Membrane penetrating peptides and uses thereof |
| 09/12/2003 | WO2001090197A9 Synthetic peptides and uses therefore |
| 09/11/2003 | US20030171568 Diagnosing tumor or cancer in a mammal, and inflammatory diseases or disorders; inflammatory bowel disease, colon cancer; immunoassay, immunotherapy |
| 09/11/2003 | US20030171559 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein |
| 09/11/2003 | US20030171552 A single-chain T-cell receptor covalently linked to single-chain antibody; anticarcinogenic agents for treating cancer |
| 09/11/2003 | US20030171548 Immunoreactive proteins where the percentage of immuno-reactive molecules as determined in a modified Lindmo-test is >81%; fermentation of culture of fluidized reactor; diagnosis of inflammatory and bone marrow displacing process |
| 09/11/2003 | US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 09/11/2003 | US20030171267 Albumin fusion proteins |
| 09/11/2003 | US20030170839 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/11/2003 | US20030170811 Culturing a microorganism transformed with an expression vector comprising a gene encoding an amino acid sequence of a peptide-fused atriopeptin; use as antihypertensive diuretic agent |
| 09/11/2003 | US20030170808 Polypeptide encoded by polynucleotide of given sequence; use in diagnosis and treatment of various diseases |
| 09/11/2003 | US20030170792 MAGE-3 peptides presented by HLA class ll molecules |
| 09/11/2003 | US20030170274 Activation of HCV-specific T cells |
| 09/11/2003 | US20030170263 Expression system |
| 09/11/2003 | US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/11/2003 | US20030170242 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/11/2003 | US20030170230 Use of the AHEC region permits the assembly of antibody fragments into defined multimeric complexes |
| 09/10/2003 | EP1342730A1 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 09/10/2003 | EP1341926A2 Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production |
| 09/10/2003 | EP1341912A2 Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
| 09/10/2003 | EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/10/2003 | CN1441810A Soluble CTL A4 mutant molecules and use thereof |
| 09/10/2003 | CN1441808A Chemokine receptor modulators, production and use |
| 09/10/2003 | CN1441807A Hepatitis B core antigen fusion proteins |
| 09/10/2003 | CN1440983A Human thymosin alpha-protothymulin fusion protein and its prepn and use |
| 09/09/2003 | US6617135 Multiple cytokine protein complexes |
| 09/09/2003 | US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 09/09/2003 | US6616930 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 09/06/2003 | CA2420829A1 Novel fusion protein of human igg1 heavy chain constant region and scfv antibody against venezuelan equine encephalitis virus |
| 09/04/2003 | WO2003072829A1 Nanostructures containing pna joining or functional elements |
| 09/04/2003 | WO2003072804A2 Nanostructures containing pilin protein |
| 09/04/2003 | WO2003072803A2 Nanostructures containing antibody assembly units |
| 09/04/2003 | WO2003072787A2 Method for detection of leptin receptor ligands |
| 09/04/2003 | WO2003072740A2 Novel type-1 cytokine receptor glm-r |
| 09/04/2003 | WO2003072715A2 Gasp1: a follistatin domain containing protein |
| 09/04/2003 | WO2003072035A2 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | WO2003072017A2 Macromolecular conjugates and processes for preparing same |
| 09/04/2003 | WO2003048334A3 Immunocytokines with modulated selectivity |
| 09/04/2003 | WO2003046560A3 Self-assembly molecules |
| 09/04/2003 | WO2002103016A3 Human tachykinin-related splice variants and compositions thereof |
| 09/04/2003 | WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 09/04/2003 | WO2002060919A3 Molecules with extended half-lives, compositions and uses thereof |
| 09/04/2003 | US20030167502 Human monoclonal antibodies to dendritic cells |
| 09/04/2003 | US20030166877 Reducing the immunogenicity of fusion proteins |
| 09/04/2003 | US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 09/04/2003 | US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration |
| 09/04/2003 | US20030166869 Chromatography separation using apatite |